Business
Inogen to Announce Second Quarter 2022 Financial Results on August 4, 2022
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare
About this update from Inogen, Inc
[{"type":"text","content":" GOLETA, Calif.--(BUSINESS WIRE)--\nInogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2022 financial results after market close on Thursday, August 4, 2022. The Company will host a corresponding conference call beginning at 2:00 pm PT/5:00 pm ET.\n\nIndividuals interested in listening to the conference call may do so by dialing:\n\nUS domestic callers (877) 841-3961\nInternational callers (201) 689-8589\n\nPlease reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/.\n\nA replay of the call will be available beginning, August 4, 2022, at 4:00pm PT/7:00pm ET through 4:00pm PT/7:00pm ET on August 18, 2022. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13730720. The webcast will also be available on Inogen's website for one year following the completion of the call.\n\nInogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.\n\nAbout Inogen\n\nWe are a medical technology company offering innovative respiratory products for use in the homecare setting. We primarily develop, manufacture and market innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.\n\nFor more information, please visit www.inogen.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20220707005154/en/\n\nAgnes Lee\n650.677.9138\[email protected]\n\nSource: Inogen, Inc.","length":4509,"tagName":"div"}]